Colon Cancer
New colon cancer study findings recently were reported by M.H. Chew and co-researchers
Published in Cancer Weekly, September 8th, 2009
"The study reviews characteristics and overall survival (OS) of CRC in patients a parts per thousand currency sign50 years old. Five hundred and twenty-three (14%) of 3,796 sporadic CRCs were identified. were compared for demographics, tumour characteristics, treatment, and 5-year overall specific survival. Independent prognostic factors were evaluated. The majority were males (54%) with a median age of 45 years (range 19-50 years). Sixty-three percent of the patients presented with advanced stage disease (stage III and IV), and tumours...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-09-08)
More Articles from Cancer Weekly
- Dana-Farber Cancer Institute
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia - Cancer Gene Therapy
Reports summarize cancer gene therapy study results from University of Utah - Cancer Gene Therapy
Research reports on cancer gene therapy from W. Shen and colleagues provide new insights - Cancer Vaccines
Data from National Cancer Institute provide new insights into cancer vaccines - Diabetes
Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers - DNA Vaccines
Investigators at China Pharmaceutical University have published new data on DNA vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
